Established 2016

Country breakout star and ACM New Female Vocalist nominee RaeLynn was diagnosed with Type 1 diabetes at age 12. The excellent care she received from Texas Children’s Hospital, and the experience of her family throughout her initial diagnosis, empowered her and her family to begin living safely with Type 1 diabetes. Now, she manages her disease and leads a very productive life touring for live performances, recording in the studio, writing songs and serving on Novo Nordisk’s Patient Ambassador Education Program.

The RaeLynn Diabetes Fund offers encouragement, empowerment, and a community for all of those facing diabetes. The Fund’s mission is to raise funds to support those whose lives are impacted by Type 1, Type 2, and juvenile diabetes.